Found: 16
Select item for more details and to access through your institution.
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics.
- Published in:
- mAbs, 2013, v. 5, n. 6, p. 826, doi. 10.4161/mabs.26008
- By:
- Publication type:
- Article
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 4, p. 880, doi. 10.3109/10428194.2015.1091934
- By:
- Publication type:
- Article
Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 1969, doi. 10.3109/10428194.2014.981174
- By:
- Publication type:
- Article
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 1, p. 12, doi. 10.3109/10428194.2014.894187
- By:
- Publication type:
- Article
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441
- By:
- Publication type:
- Article
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4082, doi. 10.3390/cancers16234082
- By:
- Publication type:
- Article
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 3, p. 259, doi. 10.1159/000509923
- By:
- Publication type:
- Article
Efficacy of ⁹⁰Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy of <sup>90</sup>Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.
- Published in:
- Hematological Oncology, 2014, v. 32, n. 1, p. 10, doi. 10.1002/hon.2078
- By:
- Publication type:
- Article
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442
- By:
- Publication type:
- Article
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1413, doi. 10.1634/theoncologist.2015-0227
- By:
- Publication type:
- Article
Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 6, p. 409, doi. 10.3390/biology13060409
- By:
- Publication type:
- Article
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 665, doi. 10.1111/bjh.13430
- By:
- Publication type:
- Article
A phase II study of dose-dense and dose-intense ABVD ( ABVD<sub>DD-DI</sub>) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 118, doi. 10.1111/bjh.12862
- By:
- Publication type:
- Article
Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146
- By:
- Publication type:
- Article